Biotech · Private company · Newton, MA, US
Extend Biosciences Inc.
Track this companyFree. Adds Extend Biosciences Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- EXT608Phase 1 · Safety IssuesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Phase 1 Study of EXT608 in Healthy AdultsPHASE1 · COMPLETED · started Jul 21, 2022ClinicalTrials.gov NCT05408663 · fetched Nov 12, 2026
NIH awards3
- A Phase 2 Study Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults with Hypoparathyroidism (IND146180; October 14, 2022)Fiscal year 2025 · $899.8KNIH RePORTER 5R01FD007824-02 · fetched Nov 12, 2026
- Long-acting PTH for hypoparathyroidismFiscal year 2025 · $999.6KNIH RePORTER 5R44DK138647-02 · fetched Nov 12, 2026
- Long-acting PTH for hypoparathyroidismFiscal year 2024 · $999.6KNIH RePORTER 1R44DK138647-01 · fetched Nov 12, 2026